scholarly article | Q13442814 |
P2093 | author name string | Yunpeng Liu | |
Kai Yu | |||
Shuang Wang | |||
Ying Wu | |||
Chenlu Zhang | |||
Zhi Li | |||
Lei Cui | |||
Xiaosong Yu | |||
Guoliang Zheng | |||
Zan Teng | |||
P2860 | cites work | CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth | Q24296787 |
Global cancer statistics, 2002 | Q27860562 | ||
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
Mechanism and biological significance of CD44 cleavage | Q28298070 | ||
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer | Q31789296 | ||
Molecular studies into the role of CD44 variants in metastasis in gastric cancer | Q33706667 | ||
Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis | Q35125058 | ||
Sequential expression of putative stem cell markers in gastric carcinogenesis | Q35287614 | ||
Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma | Q35577863 | ||
Frequent gene amplification predicts poor prognosis in gastric cancer | Q35933994 | ||
Molecular-pathological prognostic factors of gastric cancer: a review | Q36112136 | ||
Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer | Q36616818 | ||
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. | Q37040620 | ||
Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma | Q37234183 | ||
Cancer stem cell markers in common cancers - therapeutic implications | Q37262517 | ||
Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment | Q38212216 | ||
Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. | Q39044097 | ||
Identification of gastric cancer stem cells using the cell surface marker CD44. | Q39856772 | ||
The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer | Q39866556 | ||
De-novo expression of CD44 and survival in gastric cancer | Q42483834 | ||
Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus | Q44182041 | ||
[Expression tumor stem cell surface marker CD44 in gastric cancer and its significance]. | Q45927908 | ||
Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma | Q46051896 | ||
Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer. | Q54447886 | ||
Expression of CD44 variant exons 8-10 in gastric cancer. | Q55005136 | ||
Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma. | Q55255520 | ||
Expression of CD44 and Its Clinical Implication in Diffuse–Type and Intestinal–Type Gastric Adenocarcinomas | Q58828380 | ||
Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer | Q71707536 | ||
Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression | Q73072089 | ||
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer | Q73923952 | ||
Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression | Q74563009 | ||
Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma | Q77308619 | ||
Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis | Q77410201 | ||
Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma | Q77853317 | ||
Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer | Q82142859 | ||
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer | Q83239273 | ||
Prognostic impact of CD133 expression in gastric carcinoma | Q84586885 | ||
Gastric cancer: basic aspects | Q84899615 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3595-3606 | |
P577 | publication date | 2015-03-15 | |
P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
P1476 | title | CD44 family proteins in gastric cancer: a meta-analysis and narrative review | |
P478 | volume | 8 |
Q33728237 | A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer |
Q38601789 | Cancer stem cells in human digestive tract malignancies |
Q35955938 | Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer |
Q38845190 | Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance |
Q92073923 | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence |
Q40435121 | Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer |
Q37564476 | Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses |
Q37479140 | SALL4 promotes gastric cancer progression through activating CD44 expression |